Cited 4 times in
A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.